BRAIN ACCESS Trademark

Trademark Overview


On Wednesday, July 8, 2020, a trademark application was filed for BRAIN ACCESS with the United States Patent and Trademark Office. The USPTO has given the BRAIN ACCESS trademark a serial number of 90042690. The federal status of this trademark filing is REGISTERED as of Tuesday, January 10, 2023. This trademark is owned by Braizon Therapeutics, Inc.. The BRAIN ACCESS trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals; processing of medicinal materials; Custom manufacture of chemicals, except for chemicals for in vitro diagnostic use

Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the prevention of central nervous system diseases; pharmaceutical preparations for the prevention of central nervous system disorders; pharmaceutical preparations for the treatment of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for the prevention of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for the brain for the treatment of central nervous system diseases; pharmaceutical preparations for the brain for the treatment of central nervous system disorders; pharmaceutical preparations for the brain for the prevention of central nervous system disea...

Chemicals, namely, chemicals for in vivo industrial use for analyzing the central nervous system; chemicals used in industry for in vivo analysis of the central nervous system

Testing, inspection or research of pharmaceuticals, chemicals or cosmetics, except for chemicals for in vitro diagnostic use; testing the functionality of machines, except for machines for in vitro diagnostic use; research on machines, except for machines for in vitro diagnostic use
brain access

General Information


Serial Number90042690
Word MarkBRAIN ACCESS
Filing DateWednesday, July 8, 2020
Status700 - REGISTERED
Status DateTuesday, January 10, 2023
Registration Number6945464
Registration DateTuesday, January 10, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals; processing of medicinal materials; Custom manufacture of chemicals, except for chemicals for in vitro diagnostic use
Goods and ServicesPharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the prevention of central nervous system diseases; pharmaceutical preparations for the prevention of central nervous system disorders; pharmaceutical preparations for the treatment of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for the prevention of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for the brain for the treatment of central nervous system diseases; pharmaceutical preparations for the brain for the treatment of central nervous system disorders; pharmaceutical preparations for the brain for the prevention of central nervous system diseases; pharmaceutical preparations for the brain for the prevention of central nervous system disorders; pharmaceutical preparations for the brain for treatment of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for the brain for the prevention of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the treatment of central nervous system diseases; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the treatment of central nervous system disorders; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the prevention of central nervous system diseases; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the prevention of central nervous system disorders; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the treatment of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the prevention of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; dietary supplements for humans; dietary supplements for animals; in vivo diagnostic agents for medical purposes specifically for analyzing the central nervous system; radio-isotope markers for therapeutic or in vivo diagnostic use
Goods and ServicesChemicals, namely, chemicals for in vivo industrial use for analyzing the central nervous system; chemicals used in industry for in vivo analysis of the central nervous system
Disclaimer with Predetermined Text"BRAIN"
Goods and ServicesTesting, inspection or research of pharmaceuticals, chemicals or cosmetics, except for chemicals for in vitro diagnostic use; testing the functionality of machines, except for machines for in vitro diagnostic use; research on machines, except for machines for in vitro diagnostic use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, August 5, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, August 5, 2020
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 5, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBraizon Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBunkyo-ku, Tokyo 113-0033
JP

Party NameBraizon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBunkyo-ku, Tokyo 113-0033
JP

Party NameBraizon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBunkyo-ku, Tokyo 113-0033
JP

Trademark Events


Event DateEvent Description
Tuesday, January 10, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 10, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 22, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, September 22, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 22, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, September 22, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 21, 2022ASSIGNED TO EXAMINER
Wednesday, September 21, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, September 21, 2022ASSIGNED TO EXAMINER
Wednesday, September 21, 2022WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Tuesday, September 20, 2022CASE RETURNED TO EXAMINATION
Tuesday, September 20, 2022NOTICE OF ALLOWANCE CANCELLED
Monday, September 19, 2022ASSIGNED TO EXAMINER
Monday, September 19, 2022PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, September 15, 2022ASSIGNED TO PETITION STAFF
Monday, August 22, 2022TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, July 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 27, 2022TTAB RELEASE CASE TO TRADEMARKS
Friday, May 27, 2022OPPOSITION TERMINATED NO. 999999
Friday, May 27, 2022OPPOSITION DISMISSED NO. 999999
Monday, November 22, 2021OPPOSITION INSTITUTED NO. 999999
Wednesday, June 16, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, October 17, 2020NON-FINAL ACTION E-MAILED
Saturday, October 17, 2020NON-FINAL ACTION WRITTEN
Thursday, October 15, 2020ASSIGNED TO EXAMINER
Wednesday, August 5, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 11, 2020NEW APPLICATION ENTERED IN TRAM